Current dosing of low-molecular-weight heparins does not reflect licensed product labels: an international survey.

Barras, Michael A; Kirkpatrick, Carl M J; Green, Bruce

Barras, Michael A; Kirkpatrick, Carl M J; Green, Bruce.

Affiliation

Barras MA; School of Pharmacy, The University of Queensland, Brisbane, Queensland, Australia.

Br J Clin Pharmacol ; 69(5): 520-8, 2010 May.

Article in En | MEDLINE | ID: mdl-20573088

Subject(s)

Anticoagulants/administration & dosage; Heparin, Low-Molecular-Weight/administration & dosage; Thromboembolism/drug therapy; Australia; Body Weight; Drug Administration Schedule; Drug Dosage Calculations; Drug Labeling; Humans; New Zealand; Obesity/complications; Renal Insufficiency/complications; United Kingdom; United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thromboembolism / Heparin, Low-Molecular-Weight / Anticoagulants Type of study: Clinical_trials / Guideline Limits: Humans Country/Region as subject: America do norte / Europa / Oceania Language: En Journal: Br J Clin Pharmacol Year: 2010 Document type: Article Affiliation country: Australia Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google